How to achieve scalable freezing & thawing of biopharmaceuticals

micheal-eder

Michael Eder

August 9, 2021

Table of contents

Show

"Scalability" is and will remain an important topic in Biopharma. 
No matter what area of application, it will be necessary to scale-up or down at some point. Scaling-up from doing research in small lab environments with a handful of scientists to commercial production of bulk drug substances, vaccine production or cell and gene therapies entails a number of challenges.

What is scalability?

Scalability around freezing means the ability to guarantee constant stress on proteins (biopharmaceutical molecules) in all scales, filling volumes and loading scenarios.

How to enable scalability?

Single Use Support fulfils this requirement by standardizing the IFGS – ice front growth speed – for all possible scenarios regardless of the filling volume and type of bags but also regardless of the type of system, i.e. whether LabScale or LargeScale.

The "Scalability Guide" illustrates how to enable scalable results regardless of the

How to achieve scalable freezing & thawing of biopharmaceuticals

Scalability around freezing means the ability to guarantee constant stress on proteins (biopharmaceutical molecules) in all scales, filling volumes and loading scenarios.

Single Use Support fulfils this requirement by standardizing the IFGS – icefront growth speed – for all possible scenarios regardless of the filling volume and type of bags but also regardless of the type of system, i.e. whether LabScale, MidScale or LargeScale.

Scalable bulk drug substance process with single use technologies

Batch size volume and load independent controlled freezing and thawing results:

Controlled freezing and thawing with all bag sizes – from 3 liters to 300 liters. Example of freeze/thawing curves of a fully scalable process

3 liters / pre-clinical or Phase 1/2

small-scale-4-800ml

150 liters / Phase 2/3 or commercialized

pftu-16-8200ml1

300 liters / commercialized

lssp-6-50l

Freeze & Thaw Scalability Guide

Scalability around freezing means the ability to guarantee constant stress on proteins (biopharmaceutical molecules) in all scales, filling volumes and loading scenarios.Single Use Support fulfils this requirement by standardizing the IFGS – icefront growth speed – for all possible scenarios regardless of the filling volume and type of bags but also regardless of the type of system, i.e. whether LabScale, MidScale or LargeScale
micheal-eder

Michael Eder

Senior Marketing Manager

Michael Eder, MA, is Senior Marketing Manager at Single Use Support. He is expert in pharma and health communication with his 10+ years experience in pharma. After completing his master's degree in International Healthcare Management at MCI The Entrepreneurial school in Innsbruck, he has gained experience in the pharmaceutical field manufacturing and commercialization of OTC and RX drugs. Michael creates articles about Freeze Thaw applications and Platform solutions from Single Use Support and is the author of current news with Single Use Support worldwide. 

More from Michael Eder

News

Single Use Support honoured as one of the ‘Best Managed Companies’

Deloitte Austria and Raiffeisenlandesbank Niederösterreich-Wien have honoured outstandingly managed companies. Single Use Support was the only winner from Tyrol to be honoured with the title ‘Best Managed Company 2024’. 

micheal-eder

Michael Eder

September 30, 2024

News

Third consecutive Pharma Innovation Award for Single Use Support

RoSS.PADL, the homogenizing solution from Single Use Support, was awarded the 2024 Innovation Award by Pharma Manufacturing.

micheal-eder

Michael Eder

September 26, 2024

Read more about Freeze & Thaw

Freeze & Thaw

Interview with NIBRT: Innovating Freezing & Thawing in Bioprocessing

The collaboration between Single Use Support and the National Institute for Bioprocessing Research and Training (NIBRT) exemplifies a shared commitment to advancing scientific knowledge and driving innovation in the bioprocessing industry. 

micheal-eder

Michael Eder

August 13, 2024

Freeze & Thaw

Advancements in Small Volumes Drug Freezing Techniques

Freezing small volumes extends beyond laboratory settings to include commercialized manufacturing processes for small batches in biomanufacturing, like cell banking, gene therapies utilizing viral vectors, lipid nanoparticles, and fill & finish procedures.

Alexander Fuchs | Single Use Support

Alexander Fuchs

November 20, 2023

Sustainability

Sustainable Freezing in Biopharma: An Exploration of Natural Gas Usage

In the biopharmaceutical sector, the utilization of F-Gases is on a decline. However, the need for cryopreservation of drug substances will remain. In order to contribute to a more environmentally friendly freezing of drugs, more sustainable technologies need to be developed and applied. But is sustainable freezing even possible?

Alexander Fuchs | Single Use Support

Alexander Fuchs

September 6, 2023

Freeze & Thaw

Cryovessels in Biopharmaceutical Manufacture: When Does the Tank Run Out?

It is many decades since cryovessels emerged as a groundbreaking solution in the biopharmaceutical industry, enabling the safe and efficient storage of bulk drug substances. However, the introduction of plate-based freezing methods has further advanced the technology available for the freezing of biopharmaceuticals, offering improved product quality and consistency.

daniel-tischler

Daniel Tischler

July 28, 2023